Logo image of EPSN

EPSILON ENERGY LTD (EPSN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EPSN - CA2943752097 - Common Stock

4.69 USD
+0.03 (+0.64%)
Last: 11/21/2025, 8:25:20 PM
4.69 USD
0 (0%)
After Hours: 11/21/2025, 8:25:20 PM
Fundamental Rating

6

Overall EPSN gets a fundamental rating of 6 out of 10. We evaluated EPSN against 209 industry peers in the Oil, Gas & Consumable Fuels industry. EPSN has an excellent financial health rating, but there are some minor concerns on its profitability. EPSN has a bad growth rate and is valued cheaply. With these ratings, EPSN could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

EPSN had positive earnings in the past year.
In the past year EPSN had a positive cash flow from operations.
EPSN had positive earnings in each of the past 5 years.
In the past 5 years EPSN always reported a positive cash flow from operatings.
EPSN Yearly Net Income VS EBIT VS OCF VS FCFEPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

The Return On Assets of EPSN (4.66%) is better than 64.59% of its industry peers.
EPSN has a Return On Equity (5.87%) which is in line with its industry peers.
EPSN has a Return On Invested Capital of 7.03%. This is in the better half of the industry: EPSN outperforms 61.72% of its industry peers.
EPSN had an Average Return On Invested Capital over the past 3 years of 10.21%. This is significantly below the industry average of 21.66%.
Industry RankSector Rank
ROA 4.66%
ROE 5.87%
ROIC 7.03%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
EPSN Yearly ROA, ROE, ROICEPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

The Profit Margin of EPSN (12.86%) is better than 62.68% of its industry peers.
EPSN's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 29.19%, EPSN is doing good in the industry, outperforming 70.81% of the companies in the same industry.
EPSN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 74.48%, EPSN belongs to the top of the industry, outperforming 86.12% of the companies in the same industry.
EPSN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.19%
PM (TTM) 12.86%
GM 74.48%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
EPSN Yearly Profit, Operating, Gross MarginsEPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

7

2. Health

2.1 Basic Checks

EPSN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for EPSN has been reduced compared to 1 year ago.
EPSN has less shares outstanding than it did 5 years ago.
There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EPSN Yearly Shares OutstandingEPSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EPSN Yearly Total Debt VS Total AssetsEPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

EPSN has an Altman-Z score of 2.75. This is not the best score and indicates that EPSN is in the grey zone with still only limited risk for bankruptcy at the moment.
EPSN has a better Altman-Z score (2.75) than 77.99% of its industry peers.
There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.75
ROIC/WACC0.81
WACC8.7%
EPSN Yearly LT Debt VS Equity VS FCFEPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

EPSN has a Current Ratio of 1.93. This is a normal value and indicates that EPSN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of EPSN (1.93) is better than 76.56% of its industry peers.
EPSN has a Quick Ratio of 1.93. This is a normal value and indicates that EPSN is financially healthy and should not expect problems in meeting its short term obligations.
EPSN has a Quick ratio of 1.93. This is in the better half of the industry: EPSN outperforms 78.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
EPSN Yearly Current Assets VS Current LiabilitesEPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.00% over the past year.
Measured over the past years, EPSN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.77% on average per year.
The Revenue has grown by 46.76% in the past year. This is a very strong growth!
EPSN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.38% yearly.
EPS 1Y (TTM)96%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%350%
Revenue 1Y (TTM)46.76%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%23.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPSN Yearly Revenue VS EstimatesEPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
EPSN Yearly EPS VS EstimatesEPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2020 2023 2024 2025 0 0.1 0.2 0.3 0.4

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.57, the valuation of EPSN can be described as very reasonable.
81.82% of the companies in the same industry are more expensive than EPSN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 25.45. EPSN is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 9.58, the valuation of EPSN can be described as reasonable.
Based on the Price/Forward Earnings ratio, EPSN is valued a bit cheaper than the industry average as 76.56% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.46, EPSN is valued rather cheaply.
Industry RankSector Rank
PE 9.57
Fwd PE 9.58
EPSN Price Earnings VS Forward Price EarningsEPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

EPSN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EPSN is cheaper than 84.69% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EPSN is valued a bit cheaper than the industry average as 76.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.41
EV/EBITDA 3.54
EPSN Per share dataEPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

EPSN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of EPSN may justify a higher PE ratio.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.36%, EPSN is a good candidate for dividend investing.
In the last 3 months the price of EPSN has falen by -22.61%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 5.91, EPSN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.42, EPSN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.36%

5.2 History

EPSN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EPSN Yearly Dividends per shareEPSN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

93.55% of the earnings are spent on dividend by EPSN. This is not a sustainable payout ratio.
DP93.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPSN Yearly Income VS Free CF VS DividendEPSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M
EPSN Dividend Payout.EPSN Dividend Payout, showing the Payout Ratio.EPSN Dividend Payout.PayoutRetained Earnings

EPSILON ENERGY LTD

NASDAQ:EPSN (11/21/2025, 8:25:20 PM)

After market: 4.69 0 (0%)

4.69

+0.03 (+0.64%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-17 2026-03-17
Inst Owners75.39%
Inst Owner Change-93.55%
Ins Owners4.75%
Ins Owner Change0.82%
Market Cap103.46M
Revenue(TTM)45.71M
Net Income(TTM)5.88M
Analysts82.86
Price Target8.57 (82.73%)
Short Float %1.91%
Short Ratio2.09
Dividend
Industry RankSector Rank
Dividend Yield 5.36%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP93.55%
Div Incr Years0
Div Non Decr Years2
Ex-Date09-15 2025-09-15 (0.0625)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)163.48%
Min EPS beat(2)132.84%
Max EPS beat(2)194.12%
EPS beat(4)3
Avg EPS beat(4)77.96%
Min EPS beat(4)-41.18%
Max EPS beat(4)194.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.62%
Min Revenue beat(2)-23.45%
Max Revenue beat(2)-3.78%
Revenue beat(4)1
Avg Revenue beat(4)1.29%
Min Revenue beat(4)-23.45%
Max Revenue beat(4)35.29%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.57
Fwd PE 9.58
P/S 2.26
P/FCF 10.41
P/OCF 3.99
P/B 1.03
P/tB 1.03
EV/EBITDA 3.54
EPS(TTM)0.49
EY10.45%
EPS(NY)0.49
Fwd EY10.44%
FCF(TTM)0.45
FCFY9.6%
OCF(TTM)1.17
OCFY25.04%
SpS2.07
BVpS4.54
TBVpS4.54
PEG (NY)0.05
PEG (5Y)N/A
Graham Number7.08
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 5.87%
ROCE 11.46%
ROIC 7.03%
ROICexc 7.9%
ROICexgc 7.9%
OM 29.19%
PM (TTM) 12.86%
GM 74.48%
FCFM 21.73%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
ROICexc(3y)15.79%
ROICexc(5y)13.41%
ROICexgc(3y)15.79%
ROICexgc(5y)13.41%
ROCE(3y)16.64%
ROCE(5y)14.58%
ROICexgc growth 3Y-47.2%
ROICexgc growth 5Y-12.62%
ROICexc growth 3Y-47.2%
ROICexc growth 5Y-12.62%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
F-Score7
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 129.79%
Cap/Sales 34.94%
Interest Coverage 1347.55
Cash Conversion 101.01%
Profit Quality 168.97%
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z 2.75
F-Score7
WACC8.7%
ROIC/WACC0.81
Cap/Depr(3y)242.3%
Cap/Depr(5y)173.79%
Cap/Sales(3y)62.73%
Cap/Sales(5y)45.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%350%
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.76%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%23.22%
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y195.55%
EBIT growth 3Y-37.82%
EBIT growth 5Y-6.47%
EBIT Next Year539.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y106.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.88%
OCF growth 3Y-5.61%
OCF growth 5Y5.32%

EPSILON ENERGY LTD / EPSN FAQ

What is the ChartMill fundamental rating of EPSILON ENERGY LTD (EPSN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EPSN.


What is the valuation status of EPSILON ENERGY LTD (EPSN) stock?

ChartMill assigns a valuation rating of 6 / 10 to EPSILON ENERGY LTD (EPSN). This can be considered as Fairly Valued.


Can you provide the profitability details for EPSILON ENERGY LTD?

EPSILON ENERGY LTD (EPSN) has a profitability rating of 5 / 10.


What are the PE and PB ratios of EPSILON ENERGY LTD (EPSN) stock?

The Price/Earnings (PE) ratio for EPSILON ENERGY LTD (EPSN) is 9.57 and the Price/Book (PB) ratio is 1.03.


What is the financial health of EPSILON ENERGY LTD (EPSN) stock?

The financial health rating of EPSILON ENERGY LTD (EPSN) is 9 / 10.